Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer

Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer

The concept of immunogenic cell death (ICD) has emerged as a cornerstone of therapy-induced anti-tumor immunity. To this end, the following chemotherapies were evaluated for their ability to induce ICD in non-small cell lung cancer (NSCLC) cell lines: docetaxel, carboplatin, cisplatin, oxaliplatin a...

Full description

Bibliographic Details
Main Authors: Tal Flieswasser, Jinthe Van Loenhout, Laurie Freire Boullosa, Astrid Van den Eynde, Jorrit De Waele, Jonas Van Audenaerde, Filip Lardon, Evelien Smits, Patrick Pauwels, Julie Jacobs
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Cells
Subjects:
non-small cell lung cancer
chemotherapy
immunogenic cell death
Online Access:https://www.mdpi.com/2073-4409/9/6/1474

Internet

https://www.mdpi.com/2073-4409/9/6/1474

Similar Items